Large-cap Health Care company Dr. Reddy's Laboratories has logged a -1.5% change today on a trading volume of 1,599,020. The average volume for the stock is 1,156,485.
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. Based in Hyderabad, India the company has 27,048 full time employees and a market cap of $13,134,005,248. Dr. Reddy's Laboratories currently offers its equity investors a dividend that yields 51.1% per year.
Over the last 52 weeks, RDY stock has risen 10.5%, which amounts to a -14.2% difference compared to the S&P 500. The stock's 52 week high is $16.89 whereas its 52 week low is $13.43 per share. Based on Dr. Reddy's Laboratories's average net margin growth of 8.8% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) |
|---|---|---|---|
| 2023 | 3,350,000 | 668,000 | 20 |
| 2022 | 2,992,000 | 548,000 | 18 |
| 2021 | 2,826,000 | 311,000 | 11 |
| 2020 | 2,594,000 | 236,000 | 9 |
| 2019 | 2,316,000 | 259,000 | 11 |
| 2018 | 2,225,000 | 272,000 | 12 |
